Neurodegenerative diseases are characterized by the loss of nerve cells in the brain. Thereby, the term neurodegenerative disease includes, but is not limited to dementia (including Alzheimer), Parkinson and Multiple sclerosis, among other diseases. Diagnosing these diseases poses a challenge for phyiscians as it is difficult to differentiate between pathological and age-appropriate changes.
To date, radiological diagnosis was solely based on visual appraisement. Artificial intelligence now allows the addition of objective measurement values. The brain volumetry provided by AIRAscore analyses MR-data by means of artificial intelligence. Thereby, the exact volume of dedicated brain areas is scored.
The result of this analysis are precise measurements, aiding physicians with the early and differential diagnosis of neurodegenerative diseases. Brain volumetry is an innovative tool for radiologists, neurologists and psychiatrists and plays a key role in early diagnosis. The advent of novel treatment options, however, requiring therapy inititation at an early time-point, makes quantitative brain volumetry a tool of paramount importance.
An excerpt of our references
‘Especially in the case of rare neurological diseases, we are often faced with the problem of whether an individual brain scan is already conspicuous or not. AIRAscore provides great help in our daily work.’
Prof. Dr. Ludger Schöls
Neurologist, University Hospital of Tübingen, Germany
‘With AIRAscore structure, I can support my diagnosis and diagnose changes in brain volume that I would only have been able to detect much later with a purely visual assessment. This added value pleases my patients, but also me as a doctor.’
Dr. Sören Danz
Radiologist, Sindelfingen, Germany
‘I am pleased to be able to offer my patients the additional service provided by AIRAscore. Experience shows that very many patients are afraid of dementia in old age. AIRAscore helps me to distinguish healthy from sick aging and I recognize much earlier than with the pure visual findings whether and when concrete action is needed.’
Dr. Nicola Meyer
Radiologist, Hamburg, Germany
‘I am pleased that with AIRAscore structure we now have a way to benefit from the latest scientific findings in our private practice. It only takes a few minutes until I have exact measurement values directly in my PACS, which significantly improve my reporting options.’
PD Dr. Hansjörg Rempp
Radiologist, Stuttgart, Germany
‘We now use AIRAscore structure routinely with our inpatients. The findings report gives us the necessary security here in the assessment of dementia-related diseases.’
Prof. Dr. Gerhard Eschweiler
Psychiatrist, University Hospital of Tübingen, Germany